Hypertrust Main logo




We’ve improved personalized cell therapy manufacturing at hospitals, known as point-of-care (POC), to ensure security, reliability, and scalability.


  • Immutable end-to-end audit trails to comply with standards and regulations to ensure transparency, trust and quality
  • Supply Chain orchestration and optimization helping to improve processing costs increasing ROI in personalized treatments
  • Process Automation: We’ve automated processes and introduced enterprise-grade capabilities. Clinicians can now adjust manufacturing in real-time based on patient responses
  • Highest industry standards: end to end pharma validated, FDA 21 CRF Part 11 compliant, GxP grade solution, ISBT-128 compliant labeling
  • Secure and private by default – transparent where needed 
  • Flexible and adoptable: level of product lifecycle (pre-clinical to commercialization) AND type of ATMP (allogenic, autologous, …) can be adjusted to cover future needs


We support point-of-care manufacturing, providing faster access to therapies and promoting innovation in hospital-based cell therapy development.

Our innovations aim to make personalized therapies more accessible, secure, and efficient while fostering innovation in hospital-based cell therapy manufacturing.


Strong Partners for Strong
Supply Chains

Together with our partner ecosystem, we offer extended end-to-end services tailored to specific
industrial, organisational, and regional needs.
Group 20
World Courier logo
15C45ADA5A5_400x800 1
MicrosoftTeams-image (28)
Nano 4U logo
Adva Biotechnology logo
Darz logo
Google cloud logo
AWS logo
Intel logo
DELL logo
Microsoft logo


Get to know the world-wide first supply chain planning solution to infuse resilience, intelligence, and excellence into your operations with zero latency on all levels.
Hypertrust Main logo

Book a Demo